Advanced Search

 

Study ID Status Title Patient Level Data
FMS40121 Completed A double blind, parallel group, two way study to compare a high starting dose of fluticasone (1000 µg/day) tapering off to a low maintenance dose (100 µg/day) and a continuous intermediate dose (200 µg/day) in asthmatic children aged 6 to 10 years.
FMS40137 Completed A Randomized, Double-Blind, Parallel-Group, Comparative Trial Assessing the Long Term Safety of Inhaled Fluticasone Propionate Rotadisks Via Diskhaler 50mcg BID and 100mcg BID Versus Placebo in Patients Aged 4 to 11 Years with Mild to Moderate Chronic Asthma
FMS40163 Completed Effect of fourteen weeks treatment with fluticasone propionate step-down dosing from 1000mcg/day in comparison with a fixed dose of 200mcg/day followed by an open phase with placebo administered for 8 weeks in subjects with mild asthma who exacerbate during treatment with beta-2 agonist (prn).
FMS40166 Completed A general practice, single-centre, randomised, double-blind, placebo controlled parallel group study to determine the effect of 2 weeks treatment with fluticasone propionate 2 x 250 mcg bd MDI via Volumatic spacer in patients with persistent cough and/or acute bronchitis.
FMS40175 Completed Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma.
FMS40180 Completed A placebo controlled trial studying the effect of a single dose inhaled fluticasone propionate on the bronchial diameter and the severity of exercise-induced asthma.Extensive searching has revealed that no clinical report is available for this study.
FMS40185 Completed A comparative study of the effects of fluticasone propionate (FP) and beclomethasone dipropionate (BDP) on non-specific bronchial hyperresponsiveness.Extensive searching has revealed that no clinical study report is available for this study.
FMS40190 Completed A Multicentre, Four-Week, Double-Blind, Parallel-Group Comparison of Fluticasone Propionate (50?g, 100?g, 200?g, and 400?g bd) with Beclomethasone Dipropionate (200?g bd) in Patients with Moderately Severe Asthma
FMS40201 Completed A single-centre, double-blind, cross-over study to investigate adrenal function in asthmatic children receiving treatment with inhaled beclomethasone dipropionate, 400?g/M2 or more daily, compared to half the dose of fluticasone propionate.
FMS40224 Completed A multicenter, randomized, double-blind, placebo controlled study to compare the efficacy and safety of fluticasone propionate dry powder 200mcg daily via a Diskhaler inhaler and fluticasone propionate 100mcg daily via a Diskhaler inhaler in comparison with placebo dry powder via a Diskhaler inh ...
FMS40229 Completed Efficacy of treatment with inhaled fluticasone and the effect of priming and activation of PMN cells in children with allergy and asthma.Extensive searching has revealed that no clinical report is available for this study.
FMS40230 Completed A multicentre, randomised, double-blind, parallel group, 12 month study to compare the safety and tolerability of fluticasone propionate 500mcg twice daily with beclomethasone dipropionate 1000mcg twice daily administered via the pressurised inhaler in adults with severe chronic asthma
FMS40232 Completed A single-centre, double-blind study to investigate the effects of inhaled fluticasone propionate (FP) 1500mcgdaily on inflammatory processes in the lungs of patients with chronic obstructive airways disease.
FMS40240 Completed A multicentre, randomised, double-blind, double-dummy, parallel-group, six-week study to compare the efficacy and safety of fluticasone propionate 1000µg and 2000µg daily with budesonide 1600µg daily, all via pressurised inhaler, in patients with severe chronic asthma.
FMS40243 Completed A Comparison of the Pharmacokinetics and Pharmacodynamics of Inhaled Fluticasone Propionate in Healthy Volunteers and Subjects with Chronic Obstructive Pulmonary Disease
FMS40256 Completed FLU9705: a multi-centre, parallel group, randomised, double-blind study to investigate the efficacy of fluticasone propionate 100 mcg MDI bd versus placebo MDI bd both via Babyhaler™ spacer in 1 to 5 year old children with asthma or asthma-like symptoms during a 6 months study period.
FMS40257 Completed Treatment with inhaled corticosteroids in wheezing pre-school children: is there a predictable effect?
FMS40266 Completed An open multicentre, randomized study to assess quality of life and efficacy of two internationally - approved therapeutic regimens in patients with severe bronchial asthma
FNA40001 Completed A Multicentre, Randomised, Blinded, Parallel-Group Comparison of nebulised Fluticasone Propionate 250?g bid with nebulised Budesonide 500?g bid in asthmatic children.
FNB30001 Completed A single centre, randomised, double blind, parallel group study to compare the efficacy of nebulised Fluticasone Propionate 2 mg twice daily (bd) with placebo in patients with moderate to severe chronic obstructive pulmonary disease.
FNB30005 Completed A multicentre, blinded, randomised, parallel group study to compare the efficacy and tolerability of nebulised fluticasone propionate 0.25mg bid versus nebulised beclomethasone dipropionate 0.40mg bid in children suffering from acute inflammatory conditions of the upper airways
FNLN44 Completed A single-centre, randomised, double-blind, parallel group study to determine the efficacy and tolerability of fluticasone propionate aqueous nasal spray 100 mcg four times daily, fluticasone propionate aqueous nasal spray 200 mcg four times daily and placebo aqueous nasal spray four times daily…
FNM10001 Completed The Systemic Pharmacodynamics and Pharmacokinetics of Intranasal Fluticasone Propionate and Intranasal Mometasone Furoate Administered via an Aqueous Nasal Spray in Healthy Subjects
FNM10003 Completed An open study to investigate the nasal bioavailability of intra-nasally administered fluticasone propionate administered as a solution formulation, HFA nasal MDI formulation and as the aqueous nasal spray during charcoal block in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
FNM10004 Completed An open, three-period, balanced, incomplete block crossover study in healthy subjects to investigate the effect of 7 days co-administration of fluticasone propionate aqueous nasal spray (FPANS) with ritonavir, ketoconazole, or erythromycin on serum cortisol levels Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.